The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|February 22, 2015
Europe Outsourcing Outlook 2015
For a complimentary listing in the Europe Outsourcing Outlook 2015, please download and complete the form below. The Outsourcing Outlook is published in March as a supplement to Pharmaceutical Technology Europe's regular issue.
Advertisement
For a complimentary listing in the Europe Outsourcing Outlook 2015, please download and complete the form below.
The Outsourcing Outlook is published in March as a supplement to Pharmaceutical Technology Europe's regular issue.
Submission Deadline
February 26, 2015
Form Submission Instructions
Send completed forms to
Contact us with any Questions
Chris Lawson
Associate Publisher
Tel: +44(0)124 462 9324
Submitted information will be held in confidence until publication. Final decisions regarding what details are included for publication is based on editorial judgment, reader interest, and available space.
Advertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement